메뉴 건너뛰기
The Lancet
Volumn 373, Issue 9670, 2009, Pages 1169-
Lymphadenectomy in endometrial cancer
Author keywords

[No Author keywords available]
Indexed keywords

ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TRIAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LETTER; LYMPHADENECTOMY; PRIORITY JOURNAL;
EID: 63349093168     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60675-9     Document Type: Letter
Times cited : (9)
References (3)
  • 1
    • 58149191223 scopus 로고    scopus 로고
    • Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
    • The writing committee on behalf of the ASTEC study group
    • The writing committee on behalf of the ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373 (2009) 125-136
    • (2009) Lancet , vol.373 , pp. 125-136
  • 2
    • 0032142785 scopus 로고    scopus 로고
    • Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma
    • Mohan D.S., Samuel M.A., Selim M.A., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70 (1998) 165-171
    • (1998) Gynecol Oncol , vol.70 , pp. 165-171
    • Mohan, D.S.1    Samuel, M.A.2    Selim, M.A.3
  • 3
    • 33745029084 scopus 로고    scopus 로고
    • Pelvic lymph node count as an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
    • Lutman C.V., Havrilesky L.J., Cragun J.M., et al. Pelvic lymph node count as an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102 (2006) 92-97
    • (2006) Gynecol Oncol , vol.102 , pp. 92-97
    • Lutman, C.V.1    Havrilesky, L.J.2    Cragun, J.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.